Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305575 · ClinicalTrials.gov registry record · Phase 4
Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage
A Phase 4 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03305575 is a Phase 4 study that has completed, run by Tufts Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03305575, a Phase 4 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study aims to compare the effect of chloroprocaine vs. bupivacaine on duration of motor block and duration until meeting discharge criteria in patients undergoing cervical cerclage. The hypothesis is that chloroprocaine will result in faster resolution of motor block.
Interventions
- DRUG Bupivacaine
- DRUG Chloroprocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-10-13 |
| Est. Completion | 2018-08-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305575
The ClinicalTrials.gov registry entry for NCT03305575 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03305575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305575 about?
NCT03305575 is a clinical study titled "Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage". This study aims to compare the effect of chloroprocaine vs. bupivacaine on duration of motor block and duration until meeting discharge criteria in patients undergoing cervical cerclage. The hypothesis is that chloroprocaine will result in faster resolution of motor block.
What is the current status of trial NCT03305575?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2017-10-13. Estimated completion is 2018-08-24.
What interventions are being tested in trial NCT03305575?
The interventions under investigation include: Bupivacaine (DRUG), Chloroprocaine (DRUG).
Who is sponsoring clinical trial NCT03305575?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.